Amedisys Shares Soar 12.5% After Ratings Upgrade (AMED)

Shares of Amedisys Inc. AMED are currently up 12.5% at $32.89 per share during Tuesday afternoon trading. The company's stock began to climb after Deutsche Bank upgraded its rating from Hold to Buy. Today's trading range for shares of Amedisys Inc has been between $31.30 and $33.32 per share. The consensus price target of analysts covering the company's stock is $29.64 per share. Volume of 1.2 million shares is more than double the daily average volume of 528,000 shares. Amedisys Inc. (AMED) is a health care company that focuses delivers personalized health care services to more than 35,000 individual patients and their families, in the comfort of patients' homes. Read more from Benzinga's Company news.